UniProt ID | TF3B_HUMAN | |
---|---|---|
UniProt AC | Q92994 | |
Protein Name | Transcription factor IIIB 90 kDa subunit | |
Gene Name | BRF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 677 | |
Subcellular Localization | Nucleus. | |
Protein Description | General activator of RNA polymerase which utilizes different TFIIIB complexes at structurally distinct promoters. The isoform 1 is involved in the transcription of tRNA, adenovirus VA1, 7SL and 5S RNA. Isoform 2 is required for transcription of the U6 promoter.. | |
Protein Sequence | MTGRVCRGCGGTDIELDAARGDAVCTACGSVLEDNIIVSEVQFVESSGGGSSAVGQFVSLDGAGKTPTLGGGFHVNLGKESRAQTLQNGRRHIHHLGNQLQLNQHCLDTAFNFFKMAVSRHLTRGRKMAHVIAACLYLVCRTEGTPHMLLDLSDLLQVNVYVLGKTFLLLARELCINAPAIDPCLYIPRFAHLLEFGEKNHEVSMTALRLLQRMKRDWMHTGRRPSGLCGAALLVAARMHDFRRTVKEVISVVKVCESTLRKRLTEFEDTPTSQLTIDEFMKIDLEEECDPPSYTAGQRKLRMKQLEQVLSKKLEEVEGEISSYQDAIEIELENSRPKAKGGLASLAKDGSTEDTASSLCGEEDTEDEELEAAASHLNKDLYRELLGGAPGSSEAAGSPEWGGRPPALGSLLDPLPTAASLGISDSIRECISSQSSDPKDASGDGELDLSGIDDLEIDRYILNESEARVKAELWMRENAEYLREQREKEARIAKEKELGIYKEHKPKKSCKRREPIQASTAREAIEKMLEQKKISSKINYSVLRGLSSAGGGSPHREDAQPEHSASARKLSRRRTPASRSGADPVTSVGKRLRPLVSTQPAKKVATGEALLPSSPTLGAEPARPQAVLVESGPVSYHADEEADEEEPDEEDGEPCVSALQMMGSNDYGCDGDEDDGY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
66 | Phosphorylation | SLDGAGKTPTLGGGF EECCCCCCCCCCCCE | 22.16 | 25159151 | |
68 | Phosphorylation | DGAGKTPTLGGGFHV CCCCCCCCCCCCEEE | 43.18 | 28555341 | |
79 | Ubiquitination | GFHVNLGKESRAQTL CEEEECCCHHHHHHH | 56.54 | - | |
79 | Acetylation | GFHVNLGKESRAQTL CEEEECCCHHHHHHH | 56.54 | 25953088 | |
199 | Ubiquitination | HLLEFGEKNHEVSMT HHHHHHHHCHHHHHH | 65.07 | - | |
226 | Phosphorylation | MHTGRRPSGLCGAAL HHCCCCCCCHHHHHH | 42.45 | 24719451 | |
247 | Ubiquitination | HDFRRTVKEVISVVK HHHHHHHHHHHHHHH | 45.72 | - | |
254 | Ubiquitination | KEVISVVKVCESTLR HHHHHHHHHHHHHHH | 38.73 | - | |
270 | Phosphorylation | RLTEFEDTPTSQLTI HHHCCCCCCCCCCCH | 22.67 | 22281053 | |
293 | Phosphorylation | EEECDPPSYTAGQRK CCCCCCCCCCHHHHH | 40.27 | 26552605 | |
294 | Phosphorylation | EECDPPSYTAGQRKL CCCCCCCCCHHHHHH | 13.34 | 26552605 | |
295 | Phosphorylation | ECDPPSYTAGQRKLR CCCCCCCCHHHHHHH | 28.75 | 26552605 | |
304 | Ubiquitination | GQRKLRMKQLEQVLS HHHHHHHHHHHHHHH | 45.34 | - | |
311 | Phosphorylation | KQLEQVLSKKLEEVE HHHHHHHHHHHHHHH | 28.96 | 24972180 | |
312 | Ubiquitination | QLEQVLSKKLEEVEG HHHHHHHHHHHHHHH | 58.16 | - | |
313 | Ubiquitination | LEQVLSKKLEEVEGE HHHHHHHHHHHHHHC | 58.73 | - | |
324 | Phosphorylation | VEGEISSYQDAIEIE HHHCHHCHHHHHHHE | 12.01 | 22817900 | |
333 (in isoform 3) | Ubiquitination | - | 40.13 | 21890473 | |
333 | Ubiquitination | DAIEIELENSRPKAK HHHHHEEECCCCCCC | 40.13 | 21890473 | |
340 | Ubiquitination | ENSRPKAKGGLASLA ECCCCCCCCCHHHHC | 60.69 | - | |
345 | Phosphorylation | KAKGGLASLAKDGST CCCCCHHHHCCCCCC | 33.62 | 29457462 | |
351 | Phosphorylation | ASLAKDGSTEDTASS HHHCCCCCCHHHHHH | 38.46 | 30278072 | |
352 | Phosphorylation | SLAKDGSTEDTASSL HHCCCCCCHHHHHHH | 43.33 | 21712546 | |
355 | Phosphorylation | KDGSTEDTASSLCGE CCCCCHHHHHHHCCC | 23.39 | 30278072 | |
357 | Phosphorylation | GSTEDTASSLCGEED CCCHHHHHHHCCCCC | 26.40 | 30278072 | |
357 (in isoform 8) | Phosphorylation | - | 26.40 | 27174698 | |
358 | Phosphorylation | STEDTASSLCGEEDT CCHHHHHHHCCCCCC | 25.80 | 30278072 | |
365 | Phosphorylation | SLCGEEDTEDEELEA HHCCCCCCCHHHHHH | 48.92 | 23401153 | |
367 (in isoform 8) | Phosphorylation | - | 57.68 | 27174698 | |
372 (in isoform 8) | Phosphorylation | - | 22.43 | 27174698 | |
375 | Phosphorylation | EELEAAASHLNKDLY HHHHHHHHHHCHHHH | 24.63 | 23403867 | |
382 | Phosphorylation | SHLNKDLYRELLGGA HHHCHHHHHHHHCCC | 16.51 | 28122231 | |
392 | Phosphorylation | LLGGAPGSSEAAGSP HHCCCCCCHHCCCCC | 24.77 | 27080861 | |
393 | Phosphorylation | LGGAPGSSEAAGSPE HCCCCCCHHCCCCCC | 36.85 | 27080861 | |
398 | Phosphorylation | GSSEAAGSPEWGGRP CCHHCCCCCCCCCCC | 18.21 | 25159151 | |
410 | Phosphorylation | GRPPALGSLLDPLPT CCCCCCHHHCCCCCC | 26.98 | 27080861 | |
417 | Phosphorylation | SLLDPLPTAASLGIS HHCCCCCCHHHCCCC | 42.40 | 27080861 | |
432 | Phosphorylation | DSIRECISSQSSDPK HHHHHHHHCCCCCCC | 33.70 | 29449344 | |
433 | Phosphorylation | SIRECISSQSSDPKD HHHHHHHCCCCCCCC | 17.73 | 17525332 | |
435 | Phosphorylation | RECISSQSSDPKDAS HHHHHCCCCCCCCCC | 38.36 | 25159151 | |
436 | Phosphorylation | ECISSQSSDPKDASG HHHHCCCCCCCCCCC | 50.74 | 21815630 | |
442 | Phosphorylation | SSDPKDASGDGELDL CCCCCCCCCCCCCCC | 47.77 | 27732954 | |
450 | Phosphorylation | GDGELDLSGIDDLEI CCCCCCCCCCCHHHC | 33.11 | 30278072 | |
465 | Phosphorylation | DRYILNESEARVKAE CEEECCHHHHHHHHH | 35.17 | 21815630 | |
494 | Ubiquitination | EKEARIAKEKELGIY HHHHHHHHHHHHCCC | 67.93 | - | |
496 | Ubiquitination | EARIAKEKELGIYKE HHHHHHHHHHCCCCC | 58.49 | - | |
502 | Acetylation | EKELGIYKEHKPKKS HHHHCCCCCCCCCCC | 51.96 | 25953088 | |
509 | Phosphorylation | KEHKPKKSCKRREPI CCCCCCCCCCCCCCC | 30.88 | - | |
510 (in isoform 5) | Ubiquitination | - | 5.66 | 21890473 | |
510 | Ubiquitination | EHKPKKSCKRREPIQ CCCCCCCCCCCCCCC | 5.66 | 21890473 | |
510 | Ubiquitination | EHKPKKSCKRREPIQ CCCCCCCCCCCCCCC | 5.66 | 21890473 | |
537 (in isoform 1) | Ubiquitination | - | 28.34 | 21890473 | |
537 | Ubiquitination | EQKKISSKINYSVLR HHCCHHHHHCHHHHH | 28.34 | 21890473 | |
541 | Phosphorylation | ISSKINYSVLRGLSS HHHHHCHHHHHHHHC | 15.36 | 28555341 | |
547 | Phosphorylation | YSVLRGLSSAGGGSP HHHHHHHHCCCCCCC | 22.44 | 23927012 | |
548 | Phosphorylation | SVLRGLSSAGGGSPH HHHHHHHCCCCCCCC | 35.66 | 30266825 | |
553 | Phosphorylation | LSSAGGGSPHREDAQ HHCCCCCCCCCCCCC | 22.32 | 29255136 | |
564 | Phosphorylation | EDAQPEHSASARKLS CCCCCCCCHHHHHHH | 23.43 | 23401153 | |
566 | Phosphorylation | AQPEHSASARKLSRR CCCCCCHHHHHHHCC | 31.46 | 25159151 | |
586 | Phosphorylation | RSGADPVTSVGKRLR HCCCCCCCCHHHHHH | 24.08 | 29396449 | |
587 | Phosphorylation | SGADPVTSVGKRLRP CCCCCCCCHHHHHHC | 29.16 | 29396449 | |
590 | Acetylation | DPVTSVGKRLRPLVS CCCCCHHHHHHCCCC | 46.21 | 23749302 | |
602 | Acetylation | LVSTQPAKKVATGEA CCCCCCCCCCCCCCC | 55.23 | 25953088 | |
606 | Phosphorylation | QPAKKVATGEALLPS CCCCCCCCCCCCCCC | 38.24 | 23312004 | |
613 | Phosphorylation | TGEALLPSSPTLGAE CCCCCCCCCCCCCCC | 49.25 | 26074081 | |
614 | Phosphorylation | GEALLPSSPTLGAEP CCCCCCCCCCCCCCC | 21.69 | 29255136 | |
616 | Phosphorylation | ALLPSSPTLGAEPAR CCCCCCCCCCCCCCC | 39.51 | 29255136 | |
631 | Phosphorylation | PQAVLVESGPVSYHA CCEEEEECCCCCEEC | 40.70 | 26074081 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TF3B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TF3B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TF3C5_HUMAN | GTF3C5 | physical | 10373544 | |
PHS2_HUMAN | PCBD2 | physical | 20211142 | |
TBP_HUMAN | TBP | physical | 11809839 | |
A4_HUMAN | APP | physical | 21832049 | |
TBP_HUMAN | TBP | physical | 18391023 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
616202 | Cerebellofaciodental syndrome (CFDS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-365 AND SER-450, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-365, AND MASSSPECTROMETRY. |